Randomized, Placebo-crontrolled Clinical Trial Evaluating the Efficacy and Safety of Heparan Sulfate 120 mg Prolonged-Release Tablets Compared With Placebo in Patients With Chronic Venous Disease

NCT07684833 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Venous Disease
Vein Disease
Venous Insufficiency of Leg

Interventions

DRUG: CLR Tablets - Heparan Sulphate
OTHER: CLR Placebo

Sponsor

Barbara Maglione